Had a lot of fun thinking about the Oppportunities and challenges for biomarker discovery using electronic health record data with @MarylynRitchie@kbjohnsonmd@5inghalp@ametlm - https://t.co/0ZRVSStNYT
First in person lab meeting https://t.co/RiaDmzSvAg in 18 months. Having to relearn lab social protocol w @OwlLabs for those In lab who did not join in person
So our study finding that in cancer Wnt signalling represses RAS/MAPK signalling and that this repression is is important for preventing senescence of cancer cells ..... 1/n
EpiMogrify can identify cell culture conditions required to manipulate cell fate and check out our website with these predictions at https://t.co/SVtshUBqjd.
Hospitals/informaticians who wish join their colleagues at 96 hospitals across 5 countries can join us for Phase II by filling a very short form at https://t.co/FGpqfe1r3M #COVID19@AMIAinformatics#informatics#ehr
Glad to have played a small part in the consortium's rapid response in gathering and comparing COVID related EHR across countries by bringing in Singapore's context. Many thanks to the cohesive taskforce and @zakkohane for the leading us!
COVID international effort: 5 countries, 96 hospitals clinical course by labs on ~28K cases. Key lessons in rapid response data collaborations and in country variation 1/
Congratulations Amelia Tan @ametlm and @SarahRLangley - Ethnicity-specific skeletal muscle transcriptional signatures and their relevance to insulin resistance in Singapore | The Journal of Clinical Endocrinology & Metabolism | Oxford Academic https://t.co/ar8adu4GXs
Come visit my poster G15 if you want to find out how I use a host of computational strategies to understand the biology of T2D. It will be there till 8pm today! #ISMBECCB19